Atlas Trials

Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis

Clinical trial NCT01087762 · COMPLETED

Trial details

NCT number
NCT01087762
Sponsor
UCB BIOSCIENCES GmbH
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Spondyloarthropathies
Start date
2010-03-01
Primary completion
2011-10-01
Enrollment
325

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.